News | February 24, 2024
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
We are achieving the target of developed India by making our young children healthy today
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
Subscribe To Our Newsletter & Stay Updated
